The enteric nervous system in intestinal inflammation

Canadian Journal of Gastroenterology

Volumn 10, Issue 5, 1996, Pages 335-341

  Sharkey, Keith A ^a   Parr, Edward J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Capsaicin; Crohn's disease; Enteric nervous system; Inflammation; Neurogenic inflammation; Peptides; Substance P; Ulcerative colitis; Vasoactive intestinal polypeptide

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; NEUROTRANSMITTER; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

CONFERENCE PAPER; CROHN DISEASE; ENTERITIS; INTESTINE INNERVATION; NEUROGENIC INFLAMMATION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0029742135     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1996/502865     Document Type: Conference Paper

References (92)

1. Storsteen KA, Kernohan JW, Bargen JA. The myenteric plexus in chronic ulcerative colitis. Surg Gynecol Obstet 1953;97:335-43.
2. Davis DR, Dockerty MB, Mayo CW. The myenteric plexus in regional enteritis: A study of the number of ganglion cells in the ileum in 24 cases. Surg Gynecol Obstet 1955:101:208-16.
3. Shakiroff BGP, Hinton JW. Denervation of the pelvic colon for ulcerative colitis. Surg Forum 1950;1:134-9.
4. Thorek P. Vagotomy for idlopathic ulcerative colitis and regional enteritis. Results in 21 cases. JAMA 1951;145:140-6.
5. Dennis C, Eddy FD, Frykman HM, McCarthy AM, Westover D. The response to vagotomy in idiopathic uncerative colitis and regional enteritis. Ann Surg 1948; 128:479-96.
6. Lindgren S, Stewenius J, Sjölund K, Lilja B, Sundkvist G. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol 1993;28:638-42.
7. Lindgren S, Lilja B, Rosen I, Sundkvist G. Disturbed autonomic nerve function in patients with Crohn's disease. Scand J Gastroenterol 1991;26:361-6.
8. Furness JB, Costa M. The Enteric Nervous System. Edinburgh: Churchill-Livingstone, 1987.
9. Dockray GJ, Sharkey KA. Neurochemistry of visceral afferent neurones. In: Cervero F, Morrison JFB, eds. Progress in Brain Research, vol 67. Visceral Sensation. Amsterdam: Elsevier Science Publishers, 1986:133-48.
10. Holzer P. Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991;43:143-201.
11. Maggi CA. Capsaicin-sensitive nerves in the gastrointestinal tract. Arch Int Pharmacodyn 1990;303:157-66.
12. Sharkey KA. Substance P and calcitonin gene-related peptide (CGRP) in gastrointestinal inflaumation. Ann NY Acad Sci 1992;664:425-42.
13. Chahl LA, Szolcsanyi J, Lembeck F, eds. Antidromic Vasodilatation and Neurogenic Inflammation. Budapest: Akademiai Kiado, 1984.
14. Costa M, Furness JB, Gibbins IL. Chemical coding of enteric neurons. Prog Brain Res 1986:86:217-40.
15. Bornstein JC, Furness JB. Enteric neurons and their chemical coding. In: Holle GE, Wood JD, eds. Advances in the Innervation of the Gastrointestinal Tract. Amsterdam: Excerpta Medica, 1992:101-14.
16. Costa M, Brookes S, Watermam S, Mayo R. Enteric neuronal circuitry and transmitters controlling intestinal motor function. In: Holle GE, Wood JD, eds. Advances in the Innervation of the Gastrointestinal Tract. Amsterdam: Excerpta Medica, 1992:115-24.
17. Bornstein JC, Furness JB. Correlated electrophysiological and histochemical studies of submucous neurons and their contribution to understanding enteric neural circuits. J Auton Nerv Syst 1988;25:1-13.
18. Sharkey KA, Coggins PJ, Tetzlaff W, Zwiers H, Bisby MA, Davison JS. Distribution of growth-associated protein B-50 (GAP-43) in the mammalian enteric nervous system. Neuroscience 1990;38:13-20.
19. Parr EJ, Sharkey KA. The use of constitutive nuclear oncoproteins to count neurons in the enteric nervous system of the guinea-pig. Cell Tissue Res 1994:277:325-31.
20. Parr EJ, Gibson AW, Sharkey KA. C-myc antigens in the mammalian enteric nervous system. Neuroscience 1994:58:807-16.
21. Payan DG. Neuropeptides and inflammation: The role of substance P. Ann Rev Med 1989;40:341-52.
22. Miller MJS, Sadowska-Krowicka H, Jeng AY, et al. Substance P levels in experimental ileitis in guinea pigs: Effects of misoprostol. Am J Physiol 1993;265:G321-30.
23. Palmer JM, Greenwood B. Regional content of enteric substance P and vasoactive intestinal peptide during intestinal inflammation in the parasitized ferret. Neuropeptides 1993;25:95-103.
24. Eysselein VE, Reinshagen M, Cominelli F, et al. Calcitonin gene-related peptide and substance P decrease in the rabbit colon during colitis. A time study. Gastroenterology 1991;101:1211-9.
25. Swain MG, Agro A, Blennerhassett P, Stanisz A, Collins SM. Increased levels of subslance P in the myenteric plexus of trichinella-infected rats. Gastroenterology 1992;102:1913-9.
26. Hurst SM, Stanisz AM, Sharkey KA, Collins SM. Interleukin 1β-induced increase in substance P in rat myenteric plexus. Gastroenterology 1993:105:1754-60.
27. Sharkey KA, Ihns Y. The effects of experimental ileitis on vasoactive intestinal polypeptide (VIP)-immunoreactivity in the guinea pig. Gastroenterology 1993;104:A780. (Abst)
28. Kishimoto S, Kobayashi H, Shimizu S, et al. Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis. Dig Dis Sci 1992;37:1729-37.
29. Schulte-Bockholt A, Fink JG, Otterson MF, Telford GL, Hopp K, Koch TR. Gene expression of VIP in sigmoid colon from chronic ulcerative colitis (CUC). Gastroenterology 1993;104:A578. (Abst)
30. Eysselein VE, Reinshagen M, Patel A, Davis W, Nast C, Stemini C. Calcitonin gene-related peptide in inflammatory bowel disease and experimentally induced colitis. Ann NY Acad Sci 1992;657:319-27.
31. Evangelists S, Meli A. Influence of capsaicin-sensitive fibres on experimentally-induced colitis in rats. J Pharm Pharmacol 1989;41:574-5.
32. Karmeli F, Eliakim R, Rachmilewitz D. Capsaicin pretreatment augments mucosal damage in acetic acid colitis indicating the role of capsaicin sensitive afferent neurons in maintaining colonic mucosal integrity. Gastroenterology 1993;104:A833. (Abst)
33. Domek MJ, Blackman E, Vidrich A, Kao J, Baker M, Leung FW. Capsaicin pretreatment increases severity of dextran sulfate sodium (DSS)-induced colonic damage in rats. Gastroenterology 1993;104:A71. (Abst).
34. Crowe SE, Sestini P, Perdue MH. Allergic reactions of rat jejenual mucosa. Ion transport responses to luminal antigen and inflammatory mediators. Gastroenterology 1990;99:74-82.
35. MacNaughton WK, Leach KE, Prud'homme-Lalonde L, Ho W, Sharkey KA. Ionizing radiation reduces neurally evoked electrolyte transport in rat ileum through a mast cell-dependent mechanism. Gastroenterology 1994:106:324-35.
36. LaMont JT. Mucus: the front line of intestinal mucosal defense. Ann NY Acad Sci 1992;664:190-201.
37. Moore BA, Sharkey KA, Mantle M. Neural mediation of cholera toxin-induced mucin secretion in the rat small intestine. Am J Physiol 1993;265:G1050-6.
38. Laporte JL, Dauge-Geffroy MC, Chariot J, Roze C, Potet F. [Sensory fibers sensitive to capsaicin can modulate secretion of the duodenal mucus. A morphometric study in rats.] Gastroenterol Clin Biol 1993;17:535-41.
39. Martinolle JP, More J, Dubech N, Garcia-Villar R. Inverse regulation of α- and α-adrenoceptors during trinitrobenzenesulfonic acid (TNB)-induced inflammation in guinea-pig small intestine. Life Sci 1993;52:1499-508.
40. Collins SM, Blennerhassett PA, Blennerhassett MG, Vermillion DL. Impaired acetylcholine release from the myenteric plexus of Trichinella-infected rats. Am J Physiol 1989;257:G898-903.
41. Swain MG, Blennerhassett PA, Collins SM. Impaired sympathetic nerve function in the inflamed rat intestine. Gastroenterology 1991;100:675-82.
42. Collins SM, Hurst SM, Main C, et al. Effect of inflammation of enteric nerves: Cytokine-induced changes in neurotransmitter content and release. Ann NY Acad Sci 1992;664:415-24.
43. Palmer JM. Immunodulation of electrical and synaptic behavior of myenteric neurons of guinea pig small intestine during infection with Trichinella spiralis. In: Collins SM, Snape WJ, eds. Effects of Immune Cells and Inflammation on Smooth Muscle and Enteric Nerves. Boca Raton: CRC Press, 1990:181-95.
44. Wood JD. Histamine signals in enteric neuroimmune interactions. Ann NY Acad Sci 1992:664:275-83.
45. Frieling T. Different types of stimuli evoke spike discharge in submucous neurons of the large intestine driving cyclical chloride secretion. In: Holle GE, Wood JD, eds. Advances in the Innervation of the Gastrointestinal Tract. Amsterdam: Excerta Medica, 1992:425-31.
46. Gabella G. On the plasticity of form and structure of enteric ganglia. J Auton Nerv Syst 1990;30:S59-66.
47. Poncino A, Geuna S, Scherini E, Giacobini Robecchi MG, Filogamo G. DNA synthesis experimentally induced in neurons: tetraploidy or hyperdiploidy? Int J Dev Neurosci 1990;8:621-3.
48. Siemers PT, Dobbins WO. The Meissner plexus in Crohn's disease of the colon. Surg Gynecol Obstet 1974:138:39-42.
49. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992;255:1707-10.
50. Dvorak AM, Osage JE, Monohan RA, Dickersin GR. Crohn's disease: Transmission electron microscopic studies. III. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system. Hum Pathol 1980;11:620-34.
51. Steinhoff MM, Kodner IJ, DeSchryver Kecskemeti K. Axonal degeneration/necrosis: a possible ultrastructural marker for Crohn's disease. Mod Pathol 1988;1:182-7.
52. Dvorak AM, Onderdonk AB, McLeod RS, et al. Axonal necrosis of enteric autonomie nerves in continent ileal pouches: Possible implications for pathogenesis of Crohn's disease. Ann Surg 1993:217:260-71.
53. Geboes K, Rutgeerts P, Ectors N, et al. Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology 1992;103:439-47.
54. Strobach RS, Ross AH, Markin RS, Zetterman RK, Linder J. Neural patterns in inflammatory bowel disease: An immunohistochemical survey. Mod Pathol 1990;3:488-93.
55. O'Morain C, Bishop AE, McGregor GP, et al. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. Gut 1984:25:57-61.
56. Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology 1980;79:853-60.
57. Sjolund K, Schaffalitzky de Muckadell OB, Fahrenkrug J, Hakanson R, Peterson BG, Sundler F. Peptide-containing nerve fibres in the gut wall in Crohn's disease. Gut 1983;24:724-33.
58. Mazumdar S, Das KM. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. Am J Gastroenterol 1992;87:176-81.
59. Koch TR, Camey JA, Go VLW, Szurszewski JH. Altered inhibitory innervation of circular smooth muscle in Crohn's colitis. Association with decreased vasoactive intestinal polypeptide levels. Gastroenterology 1990;98:1437-44.
60. Kubota Y, Petras RE, Ottaway CA, Tubbs RR, Farmer RG, Fiocchi C. Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease. Gastroenterology 1992;102:1242-51.
61. Koch TR, Carney JA, Go VLW. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 1987:32:369-76.
62. Duffy LC, Zielezny MA, Riepenhoff Talty M, et al. Vasoactive intestinal peptide as a laboratory supplement to clinical activity index in inflammatory bowel disease. Dig Dis Sci 1989;34:1528-35.
63. Goldin E, Karmeli F, Selinger Z, Rachmilewitz D. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 1989;34:754-57.
64. Bernstein CN, Robert ME, Eysselein VE. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Am J Gastroenterol 1993;88:908-13.
65. Mantyh PW, Catton MD, Boehmer CG, et al. Receptors for sensory neuropeptides in human inflammatory diseases: Implications for the effector role of sensory neurons. Peptides 1989;10:627-45.
66. Watanabe T, Kubota Y, Sawada T, Muto T. Distribution and quantification of somatostatin in inflammatory disease. Dis Colon Rectum 1992;35:488-94.
67. Koch TR, Camey JA, Morris VA, Go VLW. Somatostatin in the idiopathic inflammatory bowel diseases. Dis Colon Rectum 1988:31:198-203.
68. Koch TR, Cave DR, Ford H, Kirsner J. Histofluorescent and radioenzymatic analysis of colonic catecholamines in man. J Auton Nerv Syst 1984; 11:383-91.
69. Kyösola K, Penttilä O, Salaspuro M. Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand J Gastroenterol 1977;12:363-7.
70. Penttilä O, Kyösola K, Klinge E, Ahonen A, Tallqvist O. Studies of rectal mucosal catecholamines in ulcerative colitis. Ann Clin Res 1975:7:32-6.
71. Geboes K, Mebis J, Rutgeerts P, Ectors N, Vantrappen G. Demonstration of nitric oxide positive neurons in Crohn's disease. Gastroenterology 1993;104:A705. (Abst)
72. Stead RH, Tomioka M, Quinonez G, Simon GT, Feiten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 1987:84:2975-9.
73. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989:97:575-85.
74. Stead RH. Nerve remodelling during intestinal inflammation. Ann NY Acad Sci 1992:664:443-55.
75. Dvorak AM, McLeod RS, Onderdonk AB, et al. Human gut mucosal mast cells: Ultrastructural observations and anatomic variation in mast cell-nerve associations in vivo. Int Arch Allergy Appl Immunol 1992:98:158-68.
76. Mikkelsen HB, Rumessen JJ. Characterization of macrophage-like cells in the external layers of human small and large intestine. Cell Tissue Res 1992:270:273-9.
77. Dvorak AM. Ultrastructure of human gastrointestinal system. Interactions among mast cells, eosinophils, nerves and muscle in human disease. In: Collins SM, Snape WJ, eds. Effects of Immune Cells and Inflammation on Smooth Muscle and Enteric Nerves. Boca Raton: CRC Press, 1990:139-66.
78. Arizono N, Matsuda S, Hattori T, Kojima Y, Maeda T, Galli SJ. Anatomical variation in mast cell nerve associations in the rat small intestine, heart, lung, and skin. Similarities of distances between neural processes and mast cells, eosinophils, or plasma cells in the jejunal lamina propria. Lab Invest 1990;62:626-34.
79. Weihe E, Nohr D, Michel S, et al. Molecular anatomy of the neuro-immune connection. Int J Neurosci 1991;59:1-23.
80. Ottaway CA. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol Clin North Am 1991;20:511-29.
81. Ottaway CA. Vasoactive intestinal peptide as a modulator of lymphocyte and immune function. Ann NY Acad Sci 1988:527:486-500.
82. Sharkey KA, Kirk DR, Graham TL. Substance P and CGRP modify lymphocyte output from the mesenteric lymphatic duct of the rat. Gastroenterology 1992;102:A757. (Abst)
83. Nilsson G, Ahlstedt S. Altered lymphocyte proliferation of immunized rats after neurological manipulation with capsaicin. Int J Immunopharmacol 1988;10:747-51.
84. Helme RD, Eglezos A, Dandie GW, Andrews PV, Boyd RL. The effect of substance P on the regional lymph node antibody response to antigenic stimulation in capsacin-retreated rats. J Immunol 1987:139:3470-3.
85. Lechin F, van der Dijs B, Insausti CL, et al. Treatment of ulcerative colitis with clonidine. J Clin Pharmacol 1985:25:255-62.
86. Sutherland LR. Clonidine in the treatment of ulcerative colitis. Can J Gastroenterol 1988;2(Suppl A):53A-6A.
87. Melander M, Almer S, Strom M. Clonidine in ulcerative colitis and proctitis. J Intern Med 1993;233:93-4. (Lett)
88. Lashner BA, Hanauer SB, Silverstein MD. Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials. Dig Dis Sci 1990:35:827-32.
89. Pullan RD, Ganesh S, Mani V, et al. Transdermal nicotine treatment for ulcerative colitis: A controlled trial. Gastroenterology 1993;104:A765. (Abst)
90. Björck S, Dahlstrom A, Ahlman H. Topical treatment of ulcerative proctitis with lidocaine. Scand J Gastroenterol 1989:24:1061-72.
91. Björck S, Dahlström A, Johansson L, Ahlman H. Treatment of the mucosa with local anaesthetics in ulcerative colitis. Agents Actions 1992;35(Suppl):C60-72.
92. McCafferty D-M, Sharkey KA, Wallace JL. Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol 1994;266:G560-7.